Procyon, University of Toronto Innovations Foundation deal

PBP will purchase university patents and technology related to PBP's Colopath non-invasive screening test for colorectal cancer for a combination of cash and stock. PBP, which previously licensed the technology from the university, will seek a partner to develop the test. ...